Yuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. The company offers medical, critical illness, accident, property, and pet insurance products. Yuanbao Inc. was incorporated in 2019 and is headquartered in Beijing, the People's Republic of China.…
Presenting on Emerging Growth Conference 96 Day 2 on September 24. Register to live stream.
Yuanbao (NASDAQ: YB) is listed on Nasdaq, where its shares trade in USD. It belongs to the Software - Application industry, part of the Technology sector, and reports about 613 employees.
The shares were at 10.61 USD on 20 November 2026, down 44.9% over 52 weeks. Its 52-week range is 10.20 USD to 23.65 USD: the price is 55.1% below the high and 4.0% above the low.
At a market capitalisation of 488.91M USD, it trades at 2.4 times trailing earnings and 2.1 times forward earnings. The median trailing P/E of its 18 largest Software - Application peers is 33.6, a discount of 93% for YB. It pays a dividend yielding 11.33% (it pays out 28% of its earnings), against a median of 1.36% among the dividend payers in that peer group.
Yuanbao reports return on equity of 39.1%, an operating margin of 32.5% and revenue up 30.1% year over year.
It holds more cash than debt, a net cash position of 5.13B CNY. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 15.61 USD is 47.2% above the current price. The next earnings report is expected on 9 December 2026.